SCHEMBL132390

SCHEMBL132390

CC1(C)OB(c2ccc(COCCOCc3ccc(B4OC(C)(C)C(C)(C)O4)cc3)cc2)OC1(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 12/20 0.59
LIPG Q9Y5X9 12/20 0.59
F11 P03951 2/20 0.51
ESR2 Q92731 1/20 0.48
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA9 Q16790 2/20 0.45
DGAT1 O75907 1/20 0.43
CA12 O43570 1/20 0.41
CA3 P07451 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41
CA7 P43166 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
F2 P00734 1/20 0.40
PRSS1 P07477 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15579345 0.94 LPL (0.53) LPLLIPGF11ESR2CA1
SCHEMBL15602713 0.92 LPL (0.51) LPLLIPGF11ESR2CA1
SCHEMBL31748365 0.91 LIPG (0.50) LPLLIPGF11ESR2CA1
SCHEMBL27168875 0.90 LPL (0.53) LPLLIPGF11ESR2CA1
SCHEMBL14790857 0.88 LPL (0.62) LPLLIPGF11ESR2CA1
SCHEMBL25226278 0.87 LIPG (0.49) LPLLIPGF11ESR2CA1
SCHEMBL257901 0.86 LIPG (0.59) LPLLIPGF11ESR2DGAT1
SCHEMBL15341547 0.86 LPL (0.46) LPLLIPGF11ESR2CA1
SCHEMBL26965783 0.85 LPL (0.44) LPLLIPGF11ESR2CA1
SCHEMBL14714802 0.84 LPL (0.61) LPLLIPGF11ESR2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3487865-B1 DINUCLEAR AND OLIGONUCLEAR METAL COMPLEXES CONTAINING TRIPODAL BIDENTATE PART LIGANDS AND THEIR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2022-11-23 EP disclosed
US-20190157578-A1 DINUCLEAR AND OLIGONUCLEAR METAL COMPLEXES CONTAINING TRIPODAL BIDENTATE PART LIGANDS AND THEIR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-05-23 US disclosed
EP-2738195-B1 Polymer and organic electronic device CAMBRIDGE DISPLAY TECH LTD (GB) 2018-04-25 EP disclosed
WO-2018019687-A1 DINUCLEAR AND OLIGONUCLEAR METAL COMPLEXES CONTAINING TRIPODAL BIDENTATE PART LIGANDS AND THEIR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2018-02-01 WO disclosed
US-9812644-B2 Composition containing dopant and co-polymers having non-conjugated spacer units and its use in OLED devices CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2017-11-07 US disclosed
US-9812644-B2 Composition containing dopant and co-polymers having non-conjugated spacer units and its use in OLED devices CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2017-11-07 US disclosed
US-9653687-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2017-05-16 US disclosed
US-9653687-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2017-05-16 US disclosed
US-9478762-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-10-25 US disclosed
US-9478762-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-10-25 US disclosed
US-20140151660-A1 POLYMER AND ORGANIC ELECTRONIC DEVICE SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2014-06-05 US disclosed
EP-2738195-A1 Polymer and organic electronic device Cambridge Display Technology Limited (GB) 2014-06-04 EP disclosed
US-20130277617-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2013-10-24 US disclosed
US-20130277617-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2013-10-24 US disclosed
US-20130228767-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK 2013-09-05 US disclosed
US-20130228767-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK 2013-09-05 US disclosed
WO-2012084114-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2012-06-28 WO disclosed
US-20120056170-A1 COMPOSITION COMPRISING AT LEAST ONE EMITTER COMPOUND AND AT LEAST ONE POLYMER HAVING CONJUGATION-INTERRUPTING UNITS MERCK PATENT GMBH (DE) 2012-03-08 US disclosed
US-20120056170-A1 COMPOSITION COMPRISING AT LEAST ONE EMITTER COMPOUND AND AT LEAST ONE POLYMER HAVING CONJUGATION-INTERRUPTING UNITS MERCK PATENT GMBH (DE) 2012-03-08 US disclosed
WO-2010136111-A1 COMPOSITION, CONTAINING AT LEAST ONE EMITTER COMPOUND AND AT LEAST ONE POLYMER WITH CONJUGATION-INTERRUPTING UNITS MERCK PATENT GMBH (DE) 2010-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190157578-A1 DINUCLEAR AND OLIGONUCLEAR METAL COMPLEXES CONTAINING TRIPODAL BIDENTATE PART LIGANDS AND THEIR USE IN ELECTRONIC DEVICES SSBP1, POLRMT, BICRA LPL 4791/4885LIPG 4455/4885F11 4143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.